sar425899 glucagon glp-1 dual agonist sanofi Receptor occupancy of glucagon-like peptide 1/glucagon receptor in individuals with type 2 diabetes Bamadutide (SAR425899) | GLP-1R/GCGR Agonist
Description
Full escalation schedules, unit conversions, weight loss data, and switching protocols.
A more mindful, wellness-forward approach to GLP-1 use
From a pharma strategy perspective, this is a prudent and timely regulatory signal
Imagine designing a medication trial hoping to demonstrate one benefitand then finding out that your study drug just happens to have significant additional health benefits
And for those exploring GLP-1s for weight loss, it's a much more sustainable way to manage weight (low and slow is the way to go)
Somehow, its becoming even harder to get a GLP-1.
